Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 1 4Phase 3 3Phase 1/2 2Phase 4 1

Status

Completed 14Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Recurrence 1Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Panitumumab × Clear all
NCT01504477 2020-03-16

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

Georgetown University

Phase 1/2 Terminated
6 enrolled 8 charts
Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT01128387 2019-12-09

Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer

University of Wisconsin, Madison

Phase 1/2 Terminated
11 enrolled 10 charts
Gastrointestinal

Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡